All Information (Except Text) for S.3021 - Gluten in Medicine Disclosure Act of 2019116th Congress (2019-2020) |
|Sponsor:||Sen. Blumenthal, Richard [D-CT] (Introduced 12/11/2019)|
|Committees:||Senate - Health, Education, Labor, and Pensions|
|Latest Action:||Senate - 12/11/2019 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed Senate
- Passed House
- To President
- Became Law
There is 1 version of this bill. View text
Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries
Short Titles - Senate
Short Titles as Introduced
Gluten in Medicine Disclosure Act of 2019
Official Titles - Senate
Official Titles as Introduced
A bill to amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug that is intended for human use and contains an ingredient that is derived directly or indirectly from a gluten-containing grain to identify each such ingredient, and for other purposes.
Actions Overview (1)
|12/11/2019||Introduced in Senate|
12/11/2019 Introduced in Senate
All Actions (1)
|12/11/2019||Read twice and referred to the Committee on Health, Education, Labor, and Pensions.|
Action By: Senate
12/11/2019 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|Committee / Subcommittee||Date||Activity||Reports|
|Senate Health, Education, Labor, and Pensions||12/11/2019||Referred to|
Subject — Policy Area:
One Policy Area term, which best describes an entire measure, is assigned to every public bill or resolution.
Latest Summary (0)
A summary is in progress.